Clarus IV-B, L.P.
Insider CIK 1700719 · GRTX 10% owner · TALS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-13 | 696,767 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-13 | 278,707 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-13 | 2,982,874 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-13 | 717,160 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-13 | 3,586,364 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-13 | 366,918 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-13 | 676,774 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-13 | 135,334 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-13 | 26,000,000 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-13 | 3,692,307 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-13 | 1,944,371 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-13 | 1,476,924 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-13 | 562,891 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-13 | 134,047 | — | $0 | 134,047 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-13 | 670,347 | — | $0 | 670,347 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-13 | 363,433 | — | $0 | 363,433 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-13 | 557,546 | — | $0 | 557,546 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-13 | 276,060 | — | $0 | 276,060 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-13 | 690,150 | — | $0 | 690,150 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-13 | 4,859,812 | — | $0 | 4,859,812 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-13 | 701 | $17.00 | $11.9K | 160,044 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-13 | 3,507 | $17.00 | $59.6K | 800,353 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-13 | 1,902 | $17.00 | $32.3K | 433,917 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-13 | 2,917 | $17.00 | $49.6K | 665,676 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-13 | 1,444 | $17.00 | $24.5K | 329,598 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-13 | 3,611 | $17.00 | $61.4K | 823,997 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-13 | 15,918 | $17.00 | $270.6K | 4,875,730 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-13 | 25,296 | — | $0 | 159,343 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-13 | 126,499 | — | $0 | 796,846 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-13 | 68,582 | — | $0 | 432,015 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-13 | 105,213 | — | $0 | 662,759 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-13 | 52,094 | — | $0 | 328,154 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-13 | 130,236 | — | $0 | 820,386 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-14 | 561,385 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-14 | 2,807,372 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-14 | 1,552,035 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-14 | 2,334,966 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-14 | 555,193 | — | $0 | 555,193 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2019-11-12 | 2019-11-14 | 19,423 | $12.00 | $233.1K | 130,444 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2019-11-12 | 2019-11-14 | 97,131 | $12.00 | $1.17M | 652,324 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2019-11-12 | 2019-11-14 | 52,660 | $12.00 | $631.9K | 353,661 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2019-11-12 | 2019-11-14 | 80,786 | $12.00 | $969.4K | 542,555 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-14 | 111,021 | — | $0 | 111,021 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-14 | 461,769 | — | $0 | 461,769 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-14 | 301,001 | — | $0 | 301,001 | SEC↗ |